Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Hydrophobic benzoic acids as inhibitors of influenza neuraminidase

Identifieur interne : 001997 ( Main/Exploration ); précédent : 001996; suivant : 001998

Hydrophobic benzoic acids as inhibitors of influenza neuraminidase

Auteurs : Venkatram R. Atigadda [États-Unis] ; Wayne J. Brouillette [États-Unis] ; Franco Duarte [États-Unis] ; Yarlagadda S. Babu [États-Unis] ; Shanta Bantia [États-Unis] ; Pooran Chand [États-Unis] ; Naiming Chu [États-Unis] ; John A. Montgomery [États-Unis] ; David A. Walsh [États-Unis] ; Elise Sudbeck [États-Unis] ; James Finley [États-Unis] ; Gillian M. Air [États-Unis] ; Ming Luo [États-Unis] ; Graeme W. Laver [Australie]

Source :

RBID : ISTEX:25FADDF10B2BEC51C8D0BA60D09E58B598CBB6B1

Descripteurs français

English descriptors

Abstract

Abstract: Neuraminidase (NA) plays a critical role in the life cycle of influenza virus and is a target for new therapeutic agents. A new benzoic acid inhibitor (11 1 ) containing a lipophilic side chain at C-3 and a guanidine at C-5 was synthesized. The X-ray structure of 4-(N-acetylamino)-5-guanidino-3-(3-pentyloxy)benzoic acid in complex with NA revealed that the lipophilic side chain binds in a newly created hydrophobic pocket formed by the movement of Glu 278 to interact with Arg 226, whereas the guanidine of 11 interacts in a negatively charged pocket created by Asp 152, Glu 120 and Glu 229. Compound 11 was highly selective for type A (H2N2) influenza NA (IC50 1 μM) over type B (B/Lee/40) influenza NA (IC50 500 μM).

Url:
DOI: 10.1016/S0968-0896(99)00197-2


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Hydrophobic benzoic acids as inhibitors of influenza neuraminidase</title>
<author>
<name sortKey="Atigadda, Venkatram R" sort="Atigadda, Venkatram R" uniqKey="Atigadda V" first="Venkatram R." last="Atigadda">Venkatram R. Atigadda</name>
</author>
<author>
<name sortKey="Brouillette, Wayne J" sort="Brouillette, Wayne J" uniqKey="Brouillette W" first="Wayne J." last="Brouillette">Wayne J. Brouillette</name>
</author>
<author>
<name sortKey="Duarte, Franco" sort="Duarte, Franco" uniqKey="Duarte F" first="Franco" last="Duarte">Franco Duarte</name>
</author>
<author>
<name sortKey="Babu, Yarlagadda S" sort="Babu, Yarlagadda S" uniqKey="Babu Y" first="Yarlagadda S." last="Babu">Yarlagadda S. Babu</name>
</author>
<author>
<name sortKey="Bantia, Shanta" sort="Bantia, Shanta" uniqKey="Bantia S" first="Shanta" last="Bantia">Shanta Bantia</name>
</author>
<author>
<name sortKey="Chand, Pooran" sort="Chand, Pooran" uniqKey="Chand P" first="Pooran" last="Chand">Pooran Chand</name>
</author>
<author>
<name sortKey="Chu, Naiming" sort="Chu, Naiming" uniqKey="Chu N" first="Naiming" last="Chu">Naiming Chu</name>
</author>
<author>
<name sortKey="Montgomery, John A" sort="Montgomery, John A" uniqKey="Montgomery J" first="John A." last="Montgomery">John A. Montgomery</name>
</author>
<author>
<name sortKey="Walsh, David A" sort="Walsh, David A" uniqKey="Walsh D" first="David A." last="Walsh">David A. Walsh</name>
</author>
<author>
<name sortKey="Sudbeck, Elise" sort="Sudbeck, Elise" uniqKey="Sudbeck E" first="Elise" last="Sudbeck">Elise Sudbeck</name>
</author>
<author>
<name sortKey="Finley, James" sort="Finley, James" uniqKey="Finley J" first="James" last="Finley">James Finley</name>
</author>
<author>
<name sortKey="Air, Gillian M" sort="Air, Gillian M" uniqKey="Air G" first="Gillian M." last="Air">Gillian M. Air</name>
</author>
<author>
<name sortKey="Luo, Ming" sort="Luo, Ming" uniqKey="Luo M" first="Ming" last="Luo">Ming Luo</name>
</author>
<author>
<name sortKey="Laver, Graeme W" sort="Laver, Graeme W" uniqKey="Laver G" first="Graeme W." last="Laver">Graeme W. Laver</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:25FADDF10B2BEC51C8D0BA60D09E58B598CBB6B1</idno>
<date when="1999" year="1999">1999</date>
<idno type="doi">10.1016/S0968-0896(99)00197-2</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-P0VR9Q8V-3/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000469</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000469</idno>
<idno type="wicri:Area/Istex/Curation">000469</idno>
<idno type="wicri:Area/Istex/Checkpoint">000797</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000797</idno>
<idno type="wicri:doubleKey">0968-0896:1999:Atigadda V:hydrophobic:benzoic:acids</idno>
<idno type="wicri:Area/Main/Merge">001A44</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:00-0077154</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000074</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000000</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000074</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000074</idno>
<idno type="wicri:doubleKey">0968-0896:1999:Atigadda V:hydrophobic:benzoic:acids</idno>
<idno type="wicri:Area/Main/Merge">001A87</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:10632058</idno>
<idno type="wicri:Area/PubMed/Corpus">000370</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000370</idno>
<idno type="wicri:Area/PubMed/Curation">000370</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000370</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000340</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000340</idno>
<idno type="wicri:Area/Ncbi/Merge">000014</idno>
<idno type="wicri:Area/Ncbi/Curation">000014</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000014</idno>
<idno type="wicri:doubleKey">0968-0896:1999:Atigadda V:hydrophobic:benzoic:acids</idno>
<idno type="wicri:Area/Main/Merge">001A21</idno>
<idno type="wicri:Area/Main/Curation">001997</idno>
<idno type="wicri:Area/Main/Exploration">001997</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Hydrophobic benzoic acids as inhibitors of influenza neuraminidase</title>
<author>
<name sortKey="Atigadda, Venkatram R" sort="Atigadda, Venkatram R" uniqKey="Atigadda V" first="Venkatram R." last="Atigadda">Venkatram R. Atigadda</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemistry, University of Alabama at Birmingham, Birmingham, AL 35294</wicri:regionArea>
<placeName>
<region type="state">Alabama</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Brouillette, Wayne J" sort="Brouillette, Wayne J" uniqKey="Brouillette W" first="Wayne J." last="Brouillette">Wayne J. Brouillette</name>
<affiliation wicri:level="1">
<country wicri:rule="url">États-Unis</country>
</affiliation>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemistry, University of Alabama at Birmingham, Birmingham, AL 35294</wicri:regionArea>
<placeName>
<region type="state">Alabama</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Duarte, Franco" sort="Duarte, Franco" uniqKey="Duarte F" first="Franco" last="Duarte">Franco Duarte</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemistry, University of Alabama at Birmingham, Birmingham, AL 35294</wicri:regionArea>
<placeName>
<region type="state">Alabama</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Babu, Yarlagadda S" sort="Babu, Yarlagadda S" uniqKey="Babu Y" first="Yarlagadda S." last="Babu">Yarlagadda S. Babu</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>BioCryst Pharmaceuticals, Inc., 2190 Parkway Lake Drive Birmingham, AL 35244</wicri:regionArea>
<placeName>
<region type="state">Alabama</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bantia, Shanta" sort="Bantia, Shanta" uniqKey="Bantia S" first="Shanta" last="Bantia">Shanta Bantia</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>BioCryst Pharmaceuticals, Inc., 2190 Parkway Lake Drive Birmingham, AL 35244</wicri:regionArea>
<placeName>
<region type="state">Alabama</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Chand, Pooran" sort="Chand, Pooran" uniqKey="Chand P" first="Pooran" last="Chand">Pooran Chand</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>BioCryst Pharmaceuticals, Inc., 2190 Parkway Lake Drive Birmingham, AL 35244</wicri:regionArea>
<placeName>
<region type="state">Alabama</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Chu, Naiming" sort="Chu, Naiming" uniqKey="Chu N" first="Naiming" last="Chu">Naiming Chu</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>BioCryst Pharmaceuticals, Inc., 2190 Parkway Lake Drive Birmingham, AL 35244</wicri:regionArea>
<placeName>
<region type="state">Alabama</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Montgomery, John A" sort="Montgomery, John A" uniqKey="Montgomery J" first="John A." last="Montgomery">John A. Montgomery</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>BioCryst Pharmaceuticals, Inc., 2190 Parkway Lake Drive Birmingham, AL 35244</wicri:regionArea>
<placeName>
<region type="state">Alabama</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Walsh, David A" sort="Walsh, David A" uniqKey="Walsh D" first="David A." last="Walsh">David A. Walsh</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>BioCryst Pharmaceuticals, Inc., 2190 Parkway Lake Drive Birmingham, AL 35244</wicri:regionArea>
<placeName>
<region type="state">Alabama</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Sudbeck, Elise" sort="Sudbeck, Elise" uniqKey="Sudbeck E" first="Elise" last="Sudbeck">Elise Sudbeck</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Macromolecular Crystallography, University of Alabama at Birmingham, Birmingham, AL 35294</wicri:regionArea>
<placeName>
<region type="state">Alabama</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Finley, James" sort="Finley, James" uniqKey="Finley J" first="James" last="Finley">James Finley</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Macromolecular Crystallography, University of Alabama at Birmingham, Birmingham, AL 35294</wicri:regionArea>
<placeName>
<region type="state">Alabama</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Air, Gillian M" sort="Air, Gillian M" uniqKey="Air G" first="Gillian M." last="Air">Gillian M. Air</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Biochemistry and Molecular Biology, University of Oklahoma, Oklahoma City, OK 73190</wicri:regionArea>
<placeName>
<region type="state">Oklahoma</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Luo, Ming" sort="Luo, Ming" uniqKey="Luo M" first="Ming" last="Luo">Ming Luo</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Macromolecular Crystallography, University of Alabama at Birmingham, Birmingham, AL 35294</wicri:regionArea>
<placeName>
<region type="state">Alabama</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Laver, Graeme W" sort="Laver, Graeme W" uniqKey="Laver G" first="Graeme W." last="Laver">Graeme W. Laver</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>John Curtin School of Medical Research, Australian National University, Canberra 2601</wicri:regionArea>
<wicri:noRegion>Canberra 2601</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Bioorganic & Medicinal Chemistry</title>
<title level="j" type="abbrev">BMC</title>
<idno type="ISSN">0968-0896</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1999">1999</date>
<biblScope unit="volume">7</biblScope>
<biblScope unit="issue">11</biblScope>
<biblScope unit="page" from="2487">2487</biblScope>
<biblScope unit="page" to="2497">2497</biblScope>
</imprint>
<idno type="ISSN">0968-0896</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0968-0896</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antiviral</term>
<term>Antiviral Agents (chemical synthesis)</term>
<term>Antiviral Agents (pharmacology)</term>
<term>Benzenic compound</term>
<term>Benzoates (chemical synthesis)</term>
<term>Benzoates (chemistry)</term>
<term>Benzoates (pharmacology)</term>
<term>Binding site</term>
<term>Carboxamide</term>
<term>Carboxylic acid</term>
<term>Chemical synthesis</term>
<term>Crystallography, X-Ray</term>
<term>Enzyme Inhibitors (chemical synthesis)</term>
<term>Enzyme Inhibitors (pharmacology)</term>
<term>Enzyme inhibitor</term>
<term>Exo-α-sialidase</term>
<term>Guanidines</term>
<term>Hydrophobic interaction</term>
<term>Influenzavirus A</term>
<term>Inhibitor enzyme complex</term>
<term>Modeling</term>
<term>Models, Molecular</term>
<term>Molecular model</term>
<term>Neuraminidase (antagonists & inhibitors)</term>
<term>Neuraminidase (chemistry)</term>
<term>Orthomyxoviridae (drug effects)</term>
<term>Orthomyxoviridae (enzymology)</term>
<term>Protein Conformation</term>
<term>Selectivity</term>
<term>Structure activity relation</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Antienzymes (pharmacologie)</term>
<term>Antienzymes (synthèse chimique)</term>
<term>Antiviraux (pharmacologie)</term>
<term>Antiviraux (synthèse chimique)</term>
<term>Benzoates ()</term>
<term>Benzoates (pharmacologie)</term>
<term>Benzoates (synthèse chimique)</term>
<term>Conformation des protéines</term>
<term>Cristallographie aux rayons X</term>
<term>Modèles moléculaires</term>
<term>Orthomyxoviridae ()</term>
<term>Orthomyxoviridae (enzymologie)</term>
<term>Sialidase ()</term>
<term>Sialidase (antagonistes et inhibiteurs)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>Neuraminidase</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemical synthesis" xml:lang="en">
<term>Antiviral Agents</term>
<term>Benzoates</term>
<term>Enzyme Inhibitors</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Benzoates</term>
<term>Neuraminidase</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Antiviral Agents</term>
<term>Benzoates</term>
<term>Enzyme Inhibitors</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr">
<term>Sialidase</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Orthomyxoviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymologie" xml:lang="fr">
<term>Orthomyxoviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en">
<term>Orthomyxoviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Antienzymes</term>
<term>Antiviraux</term>
<term>Benzoates</term>
</keywords>
<keywords scheme="MESH" qualifier="synthèse chimique" xml:lang="fr">
<term>Antienzymes</term>
<term>Antiviraux</term>
<term>Benzoates</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Crystallography, X-Ray</term>
<term>Models, Molecular</term>
<term>Protein Conformation</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Acide carboxylique</term>
<term>Antiviral</term>
<term>Benzoates</term>
<term>Benzoïque acide(4-acétamido-3-[1-éthylpropoxy]-5-guanidino)</term>
<term>Carboxamide</term>
<term>Complexe enzyme inhibiteur</term>
<term>Composé benzénique</term>
<term>Conformation des protéines</term>
<term>Cristallographie aux rayons X</term>
<term>Exo-α-sialidase</term>
<term>Guanidines</term>
<term>Influenzavirus A</term>
<term>Inhibiteur enzyme</term>
<term>Interaction hydrophobe</term>
<term>Modèle moléculaire</term>
<term>Modèles moléculaires</term>
<term>Modélisation</term>
<term>Orthomyxoviridae</term>
<term>Relation structure activité</term>
<term>Sialidase</term>
<term>Site fixation</term>
<term>Synthèse chimique</term>
<term>Sélectivité</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Acetic</term>
<term>Acetic anhydride</term>
<term>Active site</term>
<term>Anal</term>
<term>Anhydride</term>
<term>Aqueous layer</term>
<term>Aqueous layers</term>
<term>Atigadda</term>
<term>Bana</term>
<term>Benzoic</term>
<term>Benzoic acids</term>
<term>Binding site region</term>
<term>Bioorg</term>
<term>Calcd</term>
<term>Cdcl3</term>
<term>Chem</term>
<term>Cold water</term>
<term>Crystal structure</term>
<term>Dark reaction mixture</term>
<term>Dmso</term>
<term>Ether</term>
<term>Ethyl acetate</term>
<term>Glacial acetic acid</term>
<term>Glycerol binding subsite</term>
<term>Guanidine</term>
<term>Guanidino</term>
<term>Guanidino group</term>
<term>Hydrophobic</term>
<term>Hydrophobic pocket</term>
<term>Inhibitor</term>
<term>Inhibitor complexes</term>
<term>Laver</term>
<term>Lipophilic side chain</term>
<term>Ltered</term>
<term>Methanol</term>
<term>Methyl</term>
<term>Mmol</term>
<term>Naoh</term>
<term>Neuraminidase</term>
<term>Organic layer</term>
<term>Organic layers</term>
<term>Reaction mixture</term>
<term>Room temperature</term>
<term>Sodium bicarbonate</term>
<term>Sodium sulfate</term>
<term>Subsite</term>
<term>Varghese</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: Neuraminidase (NA) plays a critical role in the life cycle of influenza virus and is a target for new therapeutic agents. A new benzoic acid inhibitor (11 1 ) containing a lipophilic side chain at C-3 and a guanidine at C-5 was synthesized. The X-ray structure of 4-(N-acetylamino)-5-guanidino-3-(3-pentyloxy)benzoic acid in complex with NA revealed that the lipophilic side chain binds in a newly created hydrophobic pocket formed by the movement of Glu 278 to interact with Arg 226, whereas the guanidine of 11 interacts in a negatively charged pocket created by Asp 152, Glu 120 and Glu 229. Compound 11 was highly selective for type A (H2N2) influenza NA (IC50 1 μM) over type B (B/Lee/40) influenza NA (IC50 500 μM).</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Australie</li>
<li>États-Unis</li>
</country>
<region>
<li>Alabama</li>
<li>Oklahoma</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Alabama">
<name sortKey="Atigadda, Venkatram R" sort="Atigadda, Venkatram R" uniqKey="Atigadda V" first="Venkatram R." last="Atigadda">Venkatram R. Atigadda</name>
</region>
<name sortKey="Air, Gillian M" sort="Air, Gillian M" uniqKey="Air G" first="Gillian M." last="Air">Gillian M. Air</name>
<name sortKey="Babu, Yarlagadda S" sort="Babu, Yarlagadda S" uniqKey="Babu Y" first="Yarlagadda S." last="Babu">Yarlagadda S. Babu</name>
<name sortKey="Bantia, Shanta" sort="Bantia, Shanta" uniqKey="Bantia S" first="Shanta" last="Bantia">Shanta Bantia</name>
<name sortKey="Brouillette, Wayne J" sort="Brouillette, Wayne J" uniqKey="Brouillette W" first="Wayne J." last="Brouillette">Wayne J. Brouillette</name>
<name sortKey="Brouillette, Wayne J" sort="Brouillette, Wayne J" uniqKey="Brouillette W" first="Wayne J." last="Brouillette">Wayne J. Brouillette</name>
<name sortKey="Chand, Pooran" sort="Chand, Pooran" uniqKey="Chand P" first="Pooran" last="Chand">Pooran Chand</name>
<name sortKey="Chu, Naiming" sort="Chu, Naiming" uniqKey="Chu N" first="Naiming" last="Chu">Naiming Chu</name>
<name sortKey="Duarte, Franco" sort="Duarte, Franco" uniqKey="Duarte F" first="Franco" last="Duarte">Franco Duarte</name>
<name sortKey="Finley, James" sort="Finley, James" uniqKey="Finley J" first="James" last="Finley">James Finley</name>
<name sortKey="Luo, Ming" sort="Luo, Ming" uniqKey="Luo M" first="Ming" last="Luo">Ming Luo</name>
<name sortKey="Montgomery, John A" sort="Montgomery, John A" uniqKey="Montgomery J" first="John A." last="Montgomery">John A. Montgomery</name>
<name sortKey="Sudbeck, Elise" sort="Sudbeck, Elise" uniqKey="Sudbeck E" first="Elise" last="Sudbeck">Elise Sudbeck</name>
<name sortKey="Walsh, David A" sort="Walsh, David A" uniqKey="Walsh D" first="David A." last="Walsh">David A. Walsh</name>
</country>
<country name="Australie">
<noRegion>
<name sortKey="Laver, Graeme W" sort="Laver, Graeme W" uniqKey="Laver G" first="Graeme W." last="Laver">Graeme W. Laver</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001997 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001997 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:25FADDF10B2BEC51C8D0BA60D09E58B598CBB6B1
   |texte=   Hydrophobic benzoic acids as inhibitors of influenza neuraminidase
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021